CERo Financial Statements From 2010 to 2025

CEROW Stock   0.02  0.01  45.53%   
CERo Therapeutics financial statements provide useful quarterly and yearly information to potential CERo Therapeutics Holdings investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on CERo Therapeutics financial statements helps investors assess CERo Therapeutics' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting CERo Therapeutics' valuation are summarized below:
There are over ninety-two available fundamental signals for CERo Therapeutics Holdings, which can be analyzed over time and compared to other ratios. All traders should should validate CERo Therapeutics' prevailing fundamental trends against the trends from 2010 to 2025 to make sure the company is sustainable.
Check CERo Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CERo Therapeutics' main balance sheet or income statement drivers, such as Net Interest Income of 121.5 K, Interest Income of 121.5 K or Depreciation And Amortization of 2.5 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. CERo financial statements analysis is a perfect complement when working with CERo Therapeutics Valuation or Volatility modules.
  
Check out the analysis of CERo Therapeutics Correlation against competitors.

CERo Therapeutics Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets7.3 M7.7 M139.2 M
Slightly volatile
Short and Long Term Debt Total1.5 M1.4 MM
Slightly volatile
Other Current Liabilities51 K53.7 K1.9 M
Pretty Stable
Total Current Liabilities5.7 M5.9 MM
Slightly volatile
Property Plant And Equipment Net3.6 M3.8 M4.5 M
Slightly volatile
Accounts Payable4.3 M4.1 M777.1 K
Slightly volatile
Cash82.8 K87.2 K3.5 M
Pretty Stable
Non Current Assets Total3.7 M3.8 M135 M
Slightly volatile
Non Currrent Assets Other160.5 K180.6 K196.9 K
Slightly volatile
Cash And Short Term Investments82.8 K87.2 K3.5 M
Pretty Stable
Common Stock Shares Outstanding9.7 M5.9 M19 M
Slightly volatile
Liabilities And Stockholders Equity7.3 M7.7 M139.2 M
Slightly volatile
Non Current Liabilities Total13.2 M20.2 M10.6 M
Slightly volatile
Capital Lease Obligations2.6 M2.7 M3.4 M
Slightly volatile
Other Current Assets10.2 M9.7 MM
Slightly volatile
Total Liabilities26.4 M26.2 M14.1 M
Slightly volatile
Property Plant And Equipment Gross5.9 M6.2 M5.4 M
Slightly volatile
Total Current Assets19.2 M9.8 MM
Slightly volatile
Capital Stock991K913
Slightly volatile
Net Working Capital9.4 M5.3 M14.9 M
Slightly volatile
Short Term DebtM1.8 M752.5 K
Slightly volatile
Common Stock468492134.7 M
Slightly volatile
Short Term Investments6.7 M7.6 M8.3 M
Slightly volatile

CERo Therapeutics Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Net Interest Income121.5 K127.9 K773.4 K
Slightly volatile
Interest Income121.5 K127.9 K773.4 K
Slightly volatile
Depreciation And Amortization2.5 K2.6 K619.2 K
Slightly volatile
Selling General Administrative2.5 K2.6 KM
Slightly volatile
Selling And Marketing Expenses2.1 M3.3 M2.2 M
Very volatile
Other Operating Expenses2.3 M3.4 M966.1 K
Slightly volatile
Research Development10.4 M11.3 M9.4 M
Slightly volatile
Total Operating Expenses2.3 M3.4 M966.1 K
Slightly volatile
Reconciled Depreciation994.6 K1.2 M825 K
Slightly volatile
Total Other Income Expense Net537 K565.3 K351.2 K
Slightly volatile

CERo Therapeutics Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation367.8 K438.2 K313.8 K
Slightly volatile
Begin Period Cash Flow36 K37.9 K22.5 M
Slightly volatile
Depreciation994.6 K1.2 M825 K
Slightly volatile
Capital Expenditures3.423.6502.8 K
Slightly volatile
End Period Cash Flow82.8287.183.5 M
Pretty Stable

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Average Payables1.6 M1.8 M1.9 M
Slightly volatile
Capex To Depreciation0.810.740.8024
Slightly volatile
Cash Per Share2.021.180.7066
Slightly volatile
Income Quality0.660.691.8811
Slightly volatile
Current Ratio1.811.910.8301
Slightly volatile
Graham Number0.150.161.2208
Slightly volatile
Capex Per Share0.00.00.0264
Pretty Stable
Interest Debt Per Share0.130.210.1597
Pretty Stable
Debt To Assets0.170.160.0479
Slightly volatile
Ebt Per Ebit0.680.960.9069
Slightly volatile
Long Term Debt To Capitalization0.01390.01560.017
Slightly volatile
Quick Ratio1.811.910.8301
Slightly volatile
Net Income Per E B T0.00110.00121.3207
Pretty Stable
Cash Ratio0.02050.02158.4907
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.651.151.7486
Slightly volatile
Debt Ratio0.170.160.0479
Slightly volatile

CERo Fundamental Market Drivers

Cash And Short Term Investments96.9 K

About CERo Therapeutics Financial Statements

CERo Therapeutics investors use historical fundamental indicators, such as CERo Therapeutics' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in CERo Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue23.1 K24.3 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for CERo Stock Analysis

When running CERo Therapeutics' price analysis, check to measure CERo Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CERo Therapeutics is operating at the current time. Most of CERo Therapeutics' value examination focuses on studying past and present price action to predict the probability of CERo Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CERo Therapeutics' price. Additionally, you may evaluate how the addition of CERo Therapeutics to your portfolios can decrease your overall portfolio volatility.